Point Of Care Molecular (POC) Diagnostics Market Growth Rate Analysis 2020 to 2026

The Point Of Care Molecular (POC) Diagnostics Market is poised for robust growth on the back of the burgeoning prevalence of infectious diseases across the globe. In recent years, the global reach of infectious diseases such as flu, tuberculosis, HIV, hepatitis C, and respiratory syncytial virus is expanding at a rapid pace. As per the CDC (Centers for Disease Control and Prevention) estimates, Influenza, a seasonal respiratory virus, was responsible for around 14 million to 21 million medical visits in the United States of America alone since October 1, 2019.

Although influenza has an approved antiviral treatment, it is important for patients to get antiviral medicines within 48 hours of symptom onset. This has led to an increase in the demand for early molecular disease diagnosis and quick result interpretation, creating lucrative growth opportunities for the Point of care molecular (POC) diagnostics market

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2210  

A study conducted at Global Market Insights, Inc. also suggests that the Point of care molecular (POC) diagnostics market is anticipated to surpass USD 2.8 billion by 2026.

It is rather undeniable that POC molecular diagnostics play a pivotal role in the detection of infectious diseases in particular. In fact, the infectious disease application segment accounted for over USD 780 million in 2019. Molecular diagnostics has significant application scope infectious diseases segment due to its several features like the lowest turnaround time and increased the specificity and sensitivity of viral detection. 

Moreover, molecular assays have also improved the diagnosis of enteric pathogens, including Clostridium difficile and organisms that are non-culturable using conventional culture methods such as gondii, Bartonella, Toxoplasma, and Leishmania. On this note, it is expected that the Point of care molecular (POC) diagnostics market will record significant revenues from the infectious diseases segment. 

POC molecular diagnostics market is essentially gaining traction in the hospitals segment in recent years. As per estimates, the hospital segment is expected to record 8% CAGR through 2020-2026. This segmental growth can be attributed to the increasing adoption of cutting-edge technologies like isothermal amplification, PCR, and sequencing in hospital settings for superior and quick diagnosis. Moreover, numerous advantages like low- cost improved treatment options would further encourage hospitals to opt for molecular diagnostic methods over the forecast period.

Request for customization @ https://www.gminsights.com/roc/2210  

On the regional front, APAC is expected to offer lucrative growth opportunities to POC molecular diagnostics market growth. This growth can be attributed to the favorable initiatives being implanted by governments for the early treatment and molecular disease diagnosis.

Citing an instance to highlight the same, Japan’s Ministry of Health, Labor, and Welfare recently introduced JANIS (Japan Nosocomial Infections Surveillance) Program to provide information on the prevalence of antimicrobial-resistant bacteria and infections in medical settings. Such initiatives by governments are likely to accelerate the POC molecular diagnostics business outlook over the forecast period.

While speaking about the competitive landscape, it is important to mention that POC molecular diagnostics market has a strong presence of well-established players. These companies are leveraging organic and inorganic growth strategies like a mergers, acquisitions, product launches to tap major market share.

Citing an example to justify the aforementioned sentence, in March 2020, Siemens Healthcare received the US FDA (Food and Drug Administration) clearance for its RapidPoint 500e Blood Gas Analyzer. The company launched this testing method to monitor ill patients, including COVID-19, in acute care settings. Notably, some prominent business players operating in the molecular diagnostics industry include Sysmex, Danaher, Vircell, Abbott Laboratories, Bio-Rad Laboratories, etc.

Browse key industry insights spread across 140 pages with 155 market data tables and 8 figures & charts from the report, Point of Care (PoC) Molecular Diagnostics Market in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/point-of-care-poc-molecular-diagnostics-market

Report Content

Chapter 3. Point of Care Molecular Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1. Increasing incidence of infectious diseases in developed and developing economies

3.3.1.2. Increasing R&D funding to reduce time required for molecular diagnostic tests

3.3.1.3. Growing awareness in developing countries about pre-disease diagnostics to control occurrence of diseases

3.3.1.4. Technological advancements in DNA sequencing and analysis

3.3.2.  Industry pitfalls and challenges

3.3.2.1. Long product development time

3.3.2.2. Complex regulatory process

3.4. Growth potential analysis

3.4.1.  By technology

3.4.2.  By application

3.4.3.  By end-use

3.5. COVID-19 impact analysis

3.6. Technology landscape

3.7. All in one diagnostics solutions overview

3.8. Porter’s analysis

3.9. Competitive landscape, 2019

3.10.  PESTEL Analysis

 

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

 

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

Comments

Post a Comment

Popular posts from this blog

Guidewires Market Growth Rate Analysis 2020 to 2026

Burgeoning demand for minimally invasive procedures is expected to fuel global Guidewires Market growth over the forecast period. Technological innovations in the healthcare sector have led to the development of hybrid guidewires that can efficiently deliver access solutions for complex anatomies, multiple pathologies, and multiple treatment modalities. The surging geriatric population suffering from lifestyle disorders has further accelerated the demand for guidewires. As per the WHO (World Health Organization), the population aged 60 years and above is anticipated to grow from 12% in 2015 to 22% by 2050. As this class of population is prone to various cardiovascular diseases, guidewires are expected to record significant demand in surgical interventions in the forthcoming time. Meanwhile, industry participants are focusing on new product innovation and development to tap major market share and expand their product portfolio. Request for a sample of this research report @ https:
Read more

Global Mobile Learning Market Overview – Key Futuristic Trends and Opportunities 2026

Global Mobile Learning Market is projected to witness a remarkable growth over the forecast period of 2020 to 2026 considering the shifting inclination towards   incorporation of technology supported training methods across educational as well as corporate sectors. With the advent of digitization, demand for mobile learning platforms has significantly increased across educational sector for providing high-quality education even in remote areas. Besides, the present situation of COVID-19 outbreak, has urged the educational institutes and corporate organizations to adopt electronic learning technologies to provide remote training to students and employees respectively. Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/4810   The industry players are also focused on offering enhanced mobile learning platforms and are using cloud technologies to strengthen their product portfolio while also   improving the overall customer experience
Read more

Rare Disease Treatment Market Rising Trends, Territorial Outlook and Industry Growth Prospects 2020-2026

  The Rare Disease Treatment Market is poised to accumulate noteworthy gains in coming years owing to the growing prevalence of rare diseases across the world. As per National Institutes of Health, nearly 30 million people in America suffer from one of the 7,000 rare diseases with only 5% of the rare disorders having substantial treatment options. The surging focus on research activities and development of novel therapeutic drugs has further elevated the rare disease treatment market value. Favorable government policies and measures for the treatment of rare disorders will also contribute towards market growth in the years to come. These initiatives are driving new drug launches across developed regions, which is expected to positively impact the rare disease treatment market growth. In fact, major diagnostic companies have been actively engaged in expanding their product portfolio recently. Citing an instance, in November 2020, Amylyx Pharmaceuticals, a leading pharmaceuticals comp
Read more